APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclic Peptide Compounds

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclic Peptide Compounds Industry Growth and Trends Forecast to 2032

23 December 202592 pages

Choose your research edition.

Industry ResearchCyclic Peptide Compounds Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclic Peptide Compounds Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Cyclic Peptide Compounds Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclic Peptide Compounds Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclic Peptide Compounds Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Cyclic Peptide Compounds market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclic Peptide Compounds is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclic Peptide Compounds include Apellis Pharmaceuticals, Bachem, Bicycle Therapeutics, Merck, Roche (Chugai Pharmabody Research), Pfizer, Novartis and Biopharma PEG Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclic Peptide Compounds market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclic Peptide Compounds market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclic Peptide Compounds market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclic Peptide Compounds.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclic Peptide Compounds market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclic Peptide Compounds Market by Company

Apellis Pharmaceuticals

Bachem

Bicycle Therapeutics

Merck

Roche (Chugai Pharmabody Research)

Pfizer

Novartis

Biopharma PEG Scientific

Cyclic Peptide Compounds Segment by Type

Synthetic Cyclic Peptide

Natural Cyclic Peptide

Cyclic Peptide Compounds Segment by Application

Biopharmaceutical

Scientific Research

Environmental Protection

Others

Cyclic Peptide Compounds Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclic Peptide Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclic Peptide Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclic Peptide Compounds.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclic Peptide Compounds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Synthetic Cyclic Peptide Table 2. Major Company of Natural Cyclic Peptide Table 3. Global Cyclic Peptide Compounds Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 5. Global Cyclic Peptide Compounds Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cyclic Peptide Compounds Sales Market Share in Value by Type (2021-2026) Table 8. Global Cyclic Peptide Compounds Price by Type (2021-2026) & (US$/Kg) Table 9. Global Cyclic Peptide Compounds Sales by Type (2027-2032) & (Tons) Table 10. Global Cyclic Peptide Compounds Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cyclic Peptide Compounds Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cyclic Peptide Compounds Sales Market Share in Value by Type (2027-2032) Table 13. Global Cyclic Peptide Compounds Price by Type (2027-2032) & (US$/Kg) Table 14. North America Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 15. North America Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 17. Europe Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 21. Latin America Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cyclic Peptide Compounds Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Cyclic Peptide Compounds Sales by Type (2021-2026) & (US$ Million) Table 24. Cyclic Peptide Compounds Industry Trends Table 25. Cyclic Peptide Compounds Industry Drivers Table 26. Cyclic Peptide Compounds Industry Opportunities and Challenges Table 27. Cyclic Peptide Compounds Industry Restraints Table 28. Global Cyclic Peptide Compounds Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cyclic Peptide Compounds Revenue Market Share by Company (2021-2026) Table 30. Global Cyclic Peptide Compounds Sales by Company (2021-2026) & (Tons) Table 31. Global Cyclic Peptide Compounds Sales Share by Company (2021-2026) Table 32. Global Cyclic Peptide Compounds Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global Cyclic Peptide Compounds Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cyclic Peptide Compounds Major Company Production Sites and Headquarters Table 35. Global Cyclic Peptide Compounds Company, Product Type & Application Table 36. Global Cyclic Peptide Compounds Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cyclic Peptide Compounds by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cyclic Peptide Compounds Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cyclic Peptide Compounds Sales by Region (2021-2026) & (Tons) Table 41. Global Cyclic Peptide Compounds Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cyclic Peptide Compounds Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cyclic Peptide Compounds Sales Market Share in Value by Region (2021-2026) Table 44. Global Cyclic Peptide Compounds Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global Cyclic Peptide Compounds Sales by Region (2027-2032) & (Tons) Table 46. Global Cyclic Peptide Compounds Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cyclic Peptide Compounds Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cyclic Peptide Compounds Sales Market Share in Value by Region (2027-2032) Table 49. Global Cyclic Peptide Compounds Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global Cyclic Peptide Compounds Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 52. Global Cyclic Peptide Compounds Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cyclic Peptide Compounds Sales Market Share in Value by Application (2021-2026) Table 55. Global Cyclic Peptide Compounds Price by Application (2021-2026) & (US$/Kg) Table 56. Global Cyclic Peptide Compounds Sales by Application (2027-2032) & (Tons) Table 57. Global Cyclic Peptide Compounds Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cyclic Peptide Compounds Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cyclic Peptide Compounds Sales Market Share in Value by Application (2027-2032) Table 60. Global Cyclic Peptide Compounds Price by Application (2027-2032) & (US$/Kg) Table 61. North America Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 62. North America Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 64. Europe Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 68. Latin America Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cyclic Peptide Compounds Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Cyclic Peptide Compounds Sales by Application (2021-2026) & (US$ Million) Table 71. Apellis Pharmaceuticals Company Information Table 72. Apellis Pharmaceuticals Business Overview Table 73. Apellis Pharmaceuticals Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio Table 75. Apellis Pharmaceuticals Recent Development Table 76. Bachem Company Information Table 77. Bachem Business Overview Table 78. Bachem Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Bachem Cyclic Peptide Compounds Product Portfolio Table 80. Bachem Recent Development Table 81. Bicycle Therapeutics Company Information Table 82. Bicycle Therapeutics Business Overview Table 83. Bicycle Therapeutics Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio Table 85. Bicycle Therapeutics Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Merck Cyclic Peptide Compounds Product Portfolio Table 90. Merck Recent Development Table 91. Roche (Chugai Pharmabody Research) Company Information Table 92. Roche (Chugai Pharmabody Research) Business Overview Table 93. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio Table 95. Roche (Chugai Pharmabody Research) Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Pfizer Cyclic Peptide Compounds Product Portfolio Table 100. Pfizer Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Novartis Cyclic Peptide Compounds Product Portfolio Table 105. Novartis Recent Development Table 106. Biopharma PEG Scientific Company Information Table 107. Biopharma PEG Scientific Business Overview Table 108. Biopharma PEG Scientific Cyclic Peptide Compounds Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio Table 110. Biopharma PEG Scientific Recent Development Table 111. North America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. North America Cyclic Peptide Compounds Sales by Country (2021-2026) & (Tons) Table 113. North America Cyclic Peptide Compounds Sales Market Share by Country (2021-2026) Table 114. North America Cyclic Peptide Compounds Sales Forecast by Country (2027-2032) & (Tons) Table 115. North America Cyclic Peptide Compounds Sales Market Share Forecast by Country (2027-2032) Table 116. North America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Cyclic Peptide Compounds Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Cyclic Peptide Compounds Market Share by Country (2021-2026) Table 119. North America Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Cyclic Peptide Compounds Market Share Forecast by Country (2027-2032) Table 121. Europe Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Europe Cyclic Peptide Compounds Sales by Country (2021-2026) & (Tons) Table 123. Europe Cyclic Peptide Compounds Sales Market Share by Country (2021-2026) Table 124. Europe Cyclic Peptide Compounds Sales Forecast by Country (2027-2032) & (Tons) Table 125. Europe Cyclic Peptide Compounds Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Cyclic Peptide Compounds Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Cyclic Peptide Compounds Market Share by Country (2021-2026) Table 129. Europe Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Cyclic Peptide Compounds Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Cyclic Peptide Compounds Sales by Country (2021-2026) & (Tons) Table 133. Asia-Pacific Cyclic Peptide Compounds Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Cyclic Peptide Compounds Sales Forecast by Country (2027-2032) & (Tons) Table 135. Asia-Pacific Cyclic Peptide Compounds Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Cyclic Peptide Compounds Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Cyclic Peptide Compounds Market Share by Country (2021-2026) Table 139. Asia-Pacific Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Cyclic Peptide Compounds Market Share Forecast by Country (2027-2032) Table 141. Latin America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Latin America Cyclic Peptide Compounds Sales by Country (2021-2026) & (Tons) Table 143. Latin America Cyclic Peptide Compounds Sales Market Share by Country (2021-2026) Table 144. Latin America Cyclic Peptide Compounds Sales Forecast by Country (2027-2032) & (Tons) Table 145. Latin America Cyclic Peptide Compounds Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Cyclic Peptide Compounds Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Cyclic Peptide Compounds Market Share by Country (2021-2026) Table 149. Latin America Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Cyclic Peptide Compounds Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Cyclic Peptide Compounds Sales by Country (2021-2026) & (Tons) Table 153. Middle East and Africa Cyclic Peptide Compounds Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Cyclic Peptide Compounds Sales Forecast by Country (2027-2032) & (Tons) Table 155. Middle East and Africa Cyclic Peptide Compounds Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Cyclic Peptide Compounds Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Cyclic Peptide Compounds Market Share by Country (2021-2026) Table 159. Middle East and Africa Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Cyclic Peptide Compounds Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Cyclic Peptide Compounds Distributors List Table 164. Cyclic Peptide Compounds Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Cyclic Peptide Compounds Image Figure 2. Global Cyclic Peptide Compounds Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclic Peptide Compounds Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclic Peptide Compounds Sales (2021-2032) & (Tons) Figure 5. Synthetic Cyclic Peptide Image Figure 6. Global Synthetic Cyclic Peptide Sales YoY Growth (2021-2032) & (Tons) Figure 7. Natural Cyclic Peptide Image Figure 8. Global Natural Cyclic Peptide Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Cyclic Peptide Compounds Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cyclic Peptide Compounds Market Share by Type 2025 VS 2032 Figure 11. North America Cyclic Peptide Compounds Sales Market Share in Volume by Type in 2025 Figure 12. North America Cyclic Peptide Compounds Sales Market Share in Value by Type in 2025 Figure 13. Europe Cyclic Peptide Compounds Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cyclic Peptide Compounds Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cyclic Peptide Compounds Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cyclic Peptide Compounds Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cyclic Peptide Compounds Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cyclic Peptide Compounds Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cyclic Peptide Compounds Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cyclic Peptide Compounds Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cyclic Peptide Compounds Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Biopharmaceutical Image Figure 24. Global Biopharmaceutical Sales YoY Growth (2021-2032) & (Tons) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (Tons) Figure 27. Environmental Protection Image Figure 28. Global Environmental Protection Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Cyclic Peptide Compounds Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cyclic Peptide Compounds Market Share by Application 2025 VS 2032 Figure 33. North America Cyclic Peptide Compounds Sales Market Share in Volume by Application in 2025 Figure 34. North America Cyclic Peptide Compounds Sales Market Share in Value by Application in 2025 Figure 35. Europe Cyclic Peptide Compounds Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cyclic Peptide Compounds Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cyclic Peptide Compounds Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cyclic Peptide Compounds Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cyclic Peptide Compounds Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cyclic Peptide Compounds Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cyclic Peptide Compounds Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cyclic Peptide Compounds Sales Market Share in Value by Application in 2025 Figure 43. North America Cyclic Peptide Compounds Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Cyclic Peptide Compounds Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cyclic Peptide Compounds Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cyclic Peptide Compounds Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cyclic Peptide Compounds Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Cyclic Peptide Compounds Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cyclic Peptide Compounds Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cyclic Peptide Compounds Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cyclic Peptide Compounds Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Cyclic Peptide Compounds Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cyclic Peptide Compounds Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cyclic Peptide Compounds Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cyclic Peptide Compounds Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Cyclic Peptide Compounds Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cyclic Peptide Compounds Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cyclic Peptide Compounds Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cyclic Peptide Compounds Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Cyclic Peptide Compounds Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cyclic Peptide Compounds Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cyclic Peptide Compounds Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cyclic Peptide Compounds Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cyclic Peptide Compounds Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Cyclic Peptide
  • Natural Cyclic Peptide
Applications
  • Biopharmaceutical
  • Scientific Research
  • Environmental Protection
  • Others
Companies covered
  • Apellis Pharmaceuticals
  • Bachem
  • Bicycle Therapeutics
  • Merck
  • Roche (Chugai Pharmabody Research)
  • Pfizer
  • Novartis
  • Biopharma PEG Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclic Peptide Compounds Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclic Peptide Compounds Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclic Peptide Compounds Market by Type
  6. 1.3.1 Synthetic Cyclic Peptide
  7. 1.3.2 Natural Cyclic Peptide
  8. 1.4 Global Cyclic Peptide Compounds Market Size by Type
  9. 1.4.1 Global Cyclic Peptide Compounds Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cyclic Peptide Compounds Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cyclic Peptide Compounds Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cyclic Peptide Compounds Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cyclic Peptide Compounds Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cyclic Peptide Compounds Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cyclic Peptide Compounds Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cyclic Peptide Compounds Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclic Peptide Compounds Industry Trends
  2. 2.2 Cyclic Peptide Compounds Industry Drivers
  3. 2.3 Cyclic Peptide Compounds Industry Opportunities and Challenges
  4. 2.4 Cyclic Peptide Compounds Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclic Peptide Compounds Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclic Peptide Compounds Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclic Peptide Compounds Price (2021-2026)
  4. 3.4 Global Cyclic Peptide Compounds Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclic Peptide Compounds Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclic Peptide Compounds Company, Product Type & Application
  7. 3.7 Global Cyclic Peptide Compounds Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclic Peptide Compounds Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclic Peptide Compounds Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclic Peptide Compounds Tier 1, Tier 2, and Tier 3
4 Cyclic Peptide Compounds Regional Status and Outlook
  1. 4.1 Global Cyclic Peptide Compounds Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclic Peptide Compounds Historic Market Size by Region
  3. 4.2.1 Global Cyclic Peptide Compounds Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclic Peptide Compounds Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclic Peptide Compounds Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclic Peptide Compounds Forecasted Market Size by Region
  7. 4.3.1 Global Cyclic Peptide Compounds Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclic Peptide Compounds Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclic Peptide Compounds Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclic Peptide Compounds by Application
  1. 5.1 Cyclic Peptide Compounds Market by Application
  2. 5.1.1 Biopharmaceutical
  3. 5.1.2 Scientific Research
  4. 5.1.3 Environmental Protection
  5. 5.1.4 Others
  6. 5.2 Global Cyclic Peptide Compounds Market Size by Application
  7. 5.2.1 Global Cyclic Peptide Compounds Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cyclic Peptide Compounds Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cyclic Peptide Compounds Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cyclic Peptide Compounds Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cyclic Peptide Compounds Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cyclic Peptide Compounds Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cyclic Peptide Compounds Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cyclic Peptide Compounds Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apellis Pharmaceuticals
  2. 6.1.1 Apellis Pharmaceuticals Company Information
  3. 6.1.2 Apellis Pharmaceuticals Business Overview
  4. 6.1.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
  6. 6.1.5 Apellis Pharmaceuticals Recent Developments
  7. 6.2 Bachem
  8. 6.2.1 Bachem Company Information
  9. 6.2.2 Bachem Business Overview
  10. 6.2.3 Bachem Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bachem Cyclic Peptide Compounds Product Portfolio
  12. 6.2.5 Bachem Recent Developments
  13. 6.3 Bicycle Therapeutics
  14. 6.3.1 Bicycle Therapeutics Company Information
  15. 6.3.2 Bicycle Therapeutics Business Overview
  16. 6.3.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
  18. 6.3.5 Bicycle Therapeutics Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Cyclic Peptide Compounds Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Roche (Chugai Pharmabody Research)
  26. 6.5.1 Roche (Chugai Pharmabody Research) Company Information
  27. 6.5.2 Roche (Chugai Pharmabody Research) Business Overview
  28. 6.5.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
  30. 6.5.5 Roche (Chugai Pharmabody Research) Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Cyclic Peptide Compounds Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Cyclic Peptide Compounds Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Biopharma PEG Scientific
  44. 6.8.1 Biopharma PEG Scientific Company Information
  45. 6.8.2 Biopharma PEG Scientific Business Overview
  46. 6.8.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
  48. 6.8.5 Biopharma PEG Scientific Recent Developments
7 North America by Country
  1. 7.1 North America Cyclic Peptide Compounds Sales by Country
  2. 7.1.1 North America Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclic Peptide Compounds Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclic Peptide Compounds Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclic Peptide Compounds Market Size by Country
  6. 7.2.1 North America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclic Peptide Compounds Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclic Peptide Compounds Sales by Country
  2. 8.1.1 Europe Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclic Peptide Compounds Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclic Peptide Compounds Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclic Peptide Compounds Market Size by Country
  6. 8.2.1 Europe Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclic Peptide Compounds Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclic Peptide Compounds Sales by Country
  2. 9.1.1 Asia-Pacific Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclic Peptide Compounds Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclic Peptide Compounds Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclic Peptide Compounds Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclic Peptide Compounds Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclic Peptide Compounds Sales by Country
  2. 10.1.1 South America Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclic Peptide Compounds Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclic Peptide Compounds Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclic Peptide Compounds Market Size by Country
  6. 10.2.1 South America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclic Peptide Compounds Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclic Peptide Compounds Sales by Country
  2. 11.1.1 Middle East and Africa Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclic Peptide Compounds Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclic Peptide Compounds Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclic Peptide Compounds Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclic Peptide Compounds Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclic Peptide Compounds Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclic Peptide Compounds Value Chain Analysis
  2. 12.1.1 Cyclic Peptide Compounds Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclic Peptide Compounds Production Mode & Process
  7. 12.2 Cyclic Peptide Compounds Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclic Peptide Compounds Distributors
  10. 12.2.3 Cyclic Peptide Compounds Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst